Université de Paris, Institut Cochin, INSERM, U1016, CNRS, UMR8104, F-75014, Paris, France.
Ludwig Institute for Cancer Research, de Duve Institute WELBIO, UCLouvain, Brussels, Belgium.
Elife. 2020 Jan 28;9:e50740. doi: 10.7554/eLife.50740.
The goal of this review is to pinpoint the specific features, including the weaknesses, of various tumor models, and to discuss the reasons why treatments that are efficient in murine tumor models often do not work in clinics. In a detailed comparison of transplanted and spontaneous tumor models, we focus on structure-function relationships in the tumor microenvironment. For instance, the architecture of the vascular tree, which depends on whether tumor cells have gone through epithelial-mesenchymal transition, is determinant for the extension of the spontaneous necrosis, and for the intratumoral localization of the immune infiltrate. Another key point is the model-dependent abundance of TGFβ in the tumor, which controls the variable susceptibility of different tumor models to treatments. Grounded in a historical perspective, this review provides a rationale for checking factors that will be key for the transition between preclinical murine models and clinical applications.
本文旨在明确各种肿瘤模型的具体特征(包括其缺陷),并讨论为什么在鼠类肿瘤模型中有效的治疗方法在临床上往往不起作用。在对移植瘤和自发瘤模型的详细比较中,我们重点关注肿瘤微环境中的结构-功能关系。例如,血管树的结构取决于肿瘤细胞是否经历上皮-间充质转化,这对于自发坏死的扩展以及免疫浸润在肿瘤内的定位具有决定性意义。另一个关键点是肿瘤中 TGFβ 的模型依赖性丰度,它控制着不同肿瘤模型对治疗的可变敏感性。本文从历史的角度出发,为检查将临床前鼠类模型和临床应用联系起来的关键因素提供了依据。